Rahoto kan sakamakon kudi na kamfanin Reata Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc. shekara-shekara na samun kudin shiga ga shekara ta 2024. Yaushe Reata Pharmaceuticals, Inc. buga rahotanni na kudi?
Reata Pharmaceuticals, Inc. jimlar kudaden shiga, ribar shiga gida da kuma sauye-sauye na canje-canje a US dollar a yau
Reata Pharmaceuticals, Inc. kudaden shiga na lokutan rahotonnin da suka gabata. Tasirin kudaden shiga na Reata Pharmaceuticals, Inc. ya ragu. Canjin ya koma -2 248 000 $. Ana nuna ƙarfin kuɗin shiga yanar gizo idan aka kwatanta da rahoton da ya gabata. Anan ne manyan alamu na Reata Pharmaceuticals, Inc.. Jadawalin hada-hadar kudi na Reata Pharmaceuticals, Inc. ya kunshi jigogi uku na manyan alamu na hada-hadar kamfanin: jimillar kadarori, kudaden shiga, sahihan kudaden shiga. Shafin rahoton hada-hadar kudade a shafin yanar gizonmu yana nuna bayanan ta hanyar kwanakin da 30/06/2018 to 31/03/2021. Reata Pharmaceuticals, Inc. jimlar kudaden shiga akan zane an nuna shi da rawaya.
Rahoton Rahoton
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
31/03/2021
944 000 $
-87.782 % ↓
-67 455 000 $
-
31/12/2020
3 192 000 $
-59.59 % ↓
-65 776 000 $
-
30/09/2020
1 401 000 $
-82.261 % ↓
-65 456 000 $
-
30/06/2020
3 073 000 $
-60.668 % ↓
-67 581 000 $
-
30/09/2019
7 898 000 $
-
-39 694 000 $
-
30/06/2019
7 813 000 $
-
-34 380 000 $
-
31/03/2019
7 726 000 $
-
-29 154 000 $
-
31/12/2018
7 899 000 $
-
-25 583 000 $
-
30/09/2018
4 766 000 $
-
-30 835 000 $
-
30/06/2018
7 519 000 $
-
-28 211 000 $
-
Nuna:
To
Rahoton kudi Reata Pharmaceuticals, Inc., tsarawa
Zamanin Reata Pharmaceuticals, Inc. rahotannin kudi: 30/06/2018, 31/12/2020, 31/03/2021. Kwanan wata da bayanan bayanan kuɗi an kafa su ne ta hanyar dokokin ƙasar da kamfanin yake gudanar da ayyukanta. Kwanan kwanan rahoton rahoton kuɗi na Reata Pharmaceuticals, Inc. na yau shine 31/03/2021. Babban riba Reata Pharmaceuticals, Inc. shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa. Babban riba Reata Pharmaceuticals, Inc. ne -33 936 000 $
Dates na kudi rahotanni Reata Pharmaceuticals, Inc.
Ribar kuɗi Reata Pharmaceuticals, Inc. shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton. Ribar kuɗi Reata Pharmaceuticals, Inc. ne -67 455 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Babban riba
Babban riba shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa.
-33 936 000 $
-44 268 000 $
-35 782 000 $
-23 711 000 $
-24 381 000 $
-21 741 000 $
-18 388 000 $
-17 410 000 $
-22 378 000 $
-15 910 000 $
Farashin farashi
Kudin shi ne yawan kuɗin da aka samar da rarraba kayayyaki da ayyuka na kamfanin.
34 880 000 $
47 460 000 $
37 183 000 $
26 784 000 $
32 279 000 $
29 554 000 $
26 114 000 $
25 309 000 $
27 144 000 $
23 429 000 $
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
944 000 $
3 192 000 $
1 401 000 $
3 073 000 $
7 898 000 $
7 813 000 $
7 726 000 $
7 899 000 $
4 766 000 $
7 519 000 $
Hanyoyin shiga
Hanyoyin sarrafa kuɗi sun karu daga asusun kasuwancin kamfanin. Alal misali, mai sayar da kaya yana haifar da samun kudin shiga ta hanyar sayar da kayayyaki, kuma likita ya karbi kuɗi daga sabis na kiwon lafiya wanda ya bayar.
-
-
-
-
7 898 000 $
7 813 000 $
7 726 000 $
7 899 000 $
4 766 000 $
7 519 000 $
Haɗin aiki
Sakamakon aiki yana da ma'auni na lissafin kudi wanda ke daidaita yawan ribar da aka samu daga ayyukan kasuwanci, bayan da ya rage kudaden aiki, kamar albashi, haɓakawa da kuma kaya na kaya da aka sayar.
-54 914 000 $
-63 980 000 $
-54 385 000 $
-40 595 000 $
-38 578 000 $
-33 659 000 $
-28 552 000 $
-24 923 000 $
-29 560 000 $
-26 652 000 $
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
-67 455 000 $
-65 776 000 $
-65 456 000 $
-67 581 000 $
-39 694 000 $
-34 380 000 $
-29 154 000 $
-25 583 000 $
-30 835 000 $
-28 211 000 $
R & D kudi
Binciken bincike da ci gaba - kudaden bincike don inganta samfurori da hanyoyin da ake samuwa ko kuma samar da sababbin samfurori da hanyoyin.
-
-
-
-
-
-
-
97 288 000 $
97 288 000 $
97 288 000 $
Ayyukan sarrafawa
Kayan aiki shine kudaden da kasuwancin ke haifarwa saboda sakamakon ayyukan kasuwanci na yau da kullum.
55 858 000 $
67 172 000 $
55 786 000 $
43 668 000 $
46 476 000 $
41 472 000 $
36 278 000 $
32 822 000 $
34 326 000 $
34 171 000 $
Abubuwan da ke yanzu
Abubuwan da ake amfani da su a yanzu shine takarda na ma'auni wanda ya wakilta dukiyar dukiyar da za'a iya juyo cikin kuɗi a cikin shekara guda.
805 520 000 $
847 338 000 $
607 032 000 $
640 467 000 $
246 531 000 $
287 211 000 $
317 472 000 $
342 273 000 $
379 818 000 $
172 412 000 $
Total dukiya
Jimlar dukiyar kuɗi ce ta kuɗin kuɗin kuɗin kuɗin kuɗin kungiyar, bashin bashi, da dukiya na kayan aiki.
815 084 000 $
857 598 000 $
612 997 000 $
652 404 000 $
259 123 000 $
300 488 000 $
331 285 000 $
345 208 000 $
382 109 000 $
174 719 000 $
Kudi na yanzu
Kasuwanci na yanzu shine kudaden kuɗin da kamfanin ya gudanar a ranar rahoton.
777 624 000 $
818 150 000 $
578 263 000 $
610 419 000 $
240 149 000 $
280 449 000 $
313 056 000 $
337 790 000 $
375 185 000 $
138 676 000 $
Yanzu bashi
Dalili na yanzu shine ɓangare na bashin da za a biya a wannan shekara (watannin 12) kuma an nuna shi a matsayin wani alhaki na yanzu da kuma ɓangare na babban kamfanonin aiki.
-
-
-
-
74 562 000 $
67 709 000 $
61 205 000 $
55 920 000 $
62 867 000 $
55 734 000 $
Jimlar kuɗi
Jimlar kuɗin kuɗi ne adadin duk kuɗin da kamfanin yake da shi a cikin asusunsa, ciki har da ƙananan kuɗi da kudade da aka gudanar a banki.
-
-
-
-
-
-
-
-
-
-
Jimlar bashi
Jimlar bashi shine haɗuwa da gajeren lokaci da dogon lokaci. Lokaci bashi ne waɗanda dole ne a biya a cikin shekara guda. Lokaci na dogon lokaci ya hada da dukan wajibai waɗanda dole ne a biya su bayan shekara guda.
-
-
-
-
326 546 000 $
333 961 000 $
335 895 000 $
330 049 000 $
344 564 000 $
342 593 000 $
Yanayin bashi
Jimlar bashi ga duk dukiya shi ne haɗin kudi wanda ya nuna yawan yawan dukiyar da kamfanin ke wakilta a matsayin bashi.
-
-
-
-
126.02 %
111.14 %
101.39 %
95.61 %
90.17 %
196.08 %
Hakki
Adalci shine adadin dukan dukiya na mai shi bayan da ya cire duk wata albashi daga dukiyar kuɗi.
369 333 000 $
417 431 000 $
185 844 000 $
231 627 000 $
-67 423 000 $
-33 473 000 $
-4 610 000 $
15 159 000 $
37 545 000 $
-167 874 000 $
Cash flow
Cash flow is bashin tsabar kuɗi da tsabar kuɗin da ake ciki a cikin kungiyar.
-
-
-
-
-40 335 000 $
-32 709 000 $
-28 732 000 $
-37 497 000 $
3 142 000 $
-25 407 000 $
Rahoton kudi na baya-bayan nan game da kudin shiga na Reata Pharmaceuticals, Inc. shine ranar 31/03/2021. A cewar sabon rahoto game da sakamakon kudi na Reata Pharmaceuticals, Inc., yawan kudaden da Reata Pharmaceuticals, Inc. ya samu ya kai 944 000 US dollar kuma ya canza zuwa -87.782% idan aka kwatanta da shekara ta gaba. Sakamakon riba na Reata Pharmaceuticals, Inc. a cikin kwata na karshe shine -67 455 000 $, karuwar riba ta karu da 0% idan aka kwatanta da bara.
Kudin hannun jari Reata Pharmaceuticals, Inc.
Kudin hannun jari Reata Pharmaceuticals, Inc.
Sharorin Reata Pharmaceuticals, Inc. a yau, farashin kayayyaki RETA yana da layi yanzu.
Rahoto kan sakamakon kudi na kamfanin Reata Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc. shekara-shekara na samun kudin shiga ga shekara ta 2024.
